Loading data
MDLZNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 38.54 bn USD | 36.44 bn USD | 36.02 bn USD | 31.5 bn USD | 28.72 bn USD |
| Cost of revenue | 27.6 bn USD | 22.18 bn USD | 22.25 bn USD | 20.18 bn USD | 17.47 bn USD |
| Gross profit | 10.94 bn USD | 14.26 bn USD | 13.76 bn USD | 11.31 bn USD | 11.25 bn USD |
| Research and development expense | 400 m USD | 400 m USD | 380 m USD | 346 m USD | 347 m USD |
| Selling, general and administrative expense | 7.17 bn USD | 7.44 bn USD | 8 bn USD | 7.38 bn USD | 6.26 bn USD |
| Operating profit | 3.55 bn USD | 6.35 bn USD | 5.5 bn USD | 3.53 bn USD | 4.65 bn USD |
| Income tax expense | 782 m USD | 1.47 bn USD | 1.54 bn USD | 865 m USD | 1.19 bn USD |
| Net income (reported basis) | 2.45 bn USD | 4.61 bn USD | 4.96 bn USD | 2.73 m USD | 4.31 m USD |
| Basic earnings per share | 1.89 USD/share | 3.44 USD/share | 3.64 USD/share | 1.97 USD/share | 3.06 USD/share |
| Diluted earnings per share | 1.89 USD/share | 3.42 USD/share | 3.62 USD/share | 1.96 USD/share | 3.04 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.